Article

Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers.

Department of Clinical Psychology II, University of Zurich, Zurich, Switzerland.
Brain Behavior and Immunity (Impact Factor: 6.13). 11/2004; 18(6):536-43. DOI: 10.1016/j.bbi.2004.01.002
Source: PubMed

ABSTRACT Smoking is a strong cardiovascular risk factor that promotes inflammation. The source of elevated pro-inflammatory cytokines in the circulation of smokers is not fully understood. We investigated the release of pro-inflammatory cytokines from circulating leukocytes stimulated with lipopolysaccharide (LPS) and its inhibition by glucocorticoids in smokers and non-smokers. Ninety-three middle-aged apparently healthy men were categorized as smokers (> 10 cigarettes/day; n = 41) or life-long non-smokers (n = 52). Peripheral cortisol was assessed from overnight urine. C-reactive protein (CRP) and tumor necrosis factor (TNF)-alpha were measured in plasma. LPS-stimulated interleukin (IL)-6 and TNF-alpha release from harvested circulating leukocytes were assessed using an in vitro whole blood assay with and without co-incubation of increasing concentrations of either dexamethasone or hydrocortisone. Glucocorticoid sensitivity was defined as the concentration of glucocorticoids required that inhibits LPS-stimulated cytokine release by 50%. Smokers had higher CRP levels (p = .005) and a trend for higher basal TNF-alpha levels (p < .07), and they also showed lower IL-6 and TNF-alpha release after LPS-stimulation than non-smokers (p's < .001). While peripheral cortisol concentration showed no significant group difference, inhibition of LPS-stimulated leukocyte IL-6 and TNF-alpha release by either glucocorticoid was enhanced in smokers as compared to non-smokers (p's < .022). The finding suggests that, in spite of a low-grade systemic inflammation, smokers have decreased LPS-stimulated cytokine release from circulating leukocytes and greater glucocorticoid sensitivity of this cytokine release than non-smokers. Circulating leukocytes unlikely contribute to the elevated pro-inflammatory cytokine levels in the blood of smokers.

Download full-text

Full-text

Available from: Ulrike Ehlert, Jun 21, 2015
1 Follower
 · 
135 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Smoking is known to be associated with oxidative stress; however, it has not been elucidated whether the oxidative response is influenced by the intensity of smoking exposure.Objectives Evaluate the effect of smoking exposure on the secretion of hydrogen peroxide (H2O2) by the peripheral blood monocytes of smokers. METHODS: A total of 25 smokers (50.3 +/- 8.8 years, 48% male) underwent the following evaluations: spirometry, pulse oximetry, body composition and total peripheral blood count. Peripheral blood monocyte (PBM) cultures were isolated and maintained, and IL-6 and TNF-alpha were measured in the plasma and in the supernatants of spontaneous and stimulated cultures. H2O2 was evaluated in the supernatants of the PBM cultures, and a subset of the PBM culture supernatants was stimulated with phorbol myristate acetate (PMA). We also evaluated 38 healthy controls (49.1+/- 8.2 years, 42% male). RESULTS: The spontaneous and stimulated monocytes' secretion of H2O2 were statistically higher in the smokers than in the healthy controls (p<0.001). The H2O2 secretions were statistically significant higher after stimulation with PMA in both groups (p<0.001). In the multiple regression analysis, we identified a positive, statistically significant association between pack-years of smoking and the spontaneous secretion of H2O2 by PBM culture, adjusted for potential confounding variables. The association between PBM culture secretion of H2O2 and the production of TNF-alpha and IL-6 was not significant. CONCLUSION: We identified a positive association between higher production of H2O2 in smokers and higher smoking exposure during life. The influence of pack-years smoking may be a key modifiable factor in oxidative stress associated to smoking.
    Journal of Inflammation 11/2012; 9(1):45. DOI:10.1186/1476-9255-9-45 · 2.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Besides biological markers such as cotinine, CO, and thiocyanate, other biological parameters are altered during pregnancy in women who smoke. Smoking women generally have a high white cell count which is related in part to pregnancy and in part to smoking but independently of other conditions. The mean corpuscular volume is increased, even in the absence of folate deficiency frequent in smoking pregnant women. The platelet count is higher than in the non-smoking mothers and the physiological pregnancy-related hyperaggregability is increased. The hypercoagulability status during pregnancy does not appear to be worsened by smoking but is insufficiently counterbalanced by fibrolysis which is less active in the smoking pregnant woman. These factors increase the risk of venous thrombosis which remains one of the main factors of pregnancy-related mortality. There are also smoking-related lipid metabolism disorders which appear independently of the pregnancy-related variations: increased total cholesterol, LDL cholesterol, and triglycerids and decreased HDL cholesterol. Combined, these factors can have an effect on the arterial walls. Vitamin levels are also lower in smoking mothers compared with their non-smoking counterparts. Levels of vitamins C, A, B12 and folates are decreased. Finding these anomalies during pregnancy in smoking mothers can be a useful mean of inciting them to stop smoking.
    Fuel and Energy Abstracts 04/2005; 34:279-291. DOI:10.1016/S0368-2315(05)83000-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cigarette smoking (CS) can impact the immune system and induce pulmonary disorders such as chronic obstructive pulmonary disease (COPD), which is currently the fourth leading cause of chronic morbidity and mortality worldwide. Accordingly, the most significant risk factor associated with COPD is exposure to cigarette smoke. The purpose of the current study is to provide an updated overview of the literature regarding the effect of CS on the immune system and lungs, the mechanism of CS-induced COPD and oxidative stress, as well as the available and potential treatment options for CS-induced COPD. An extensive literature search was conducted on the PubMed/Medline databases to review current COPD treatment research, available in the English language, dating from 1986 to 2014. Studies have investigated the mechanism by which CS elicits detrimental effects on the immune system and pulmonary function through the use of human and animal subjects. A strong relationship among continued tobacco use, oxidative stress, and exacerbation of COPD symptoms are frequently observed in COPD subjects. In addition, therapeutic approaches emphasizing smoking cessation have been developed, incorporating counseling and nicotine replacement therapy. However, the inability to reverse COPD progression establishes the need for improved preventative and therapeutic strategies, such as a combination of intensive smoking cessation treatment and pharmaceutical therapy, focusing on immune homeostasis and redox balance. CS initiates a complex interplay between oxidative stress and the immune response in COPD. Therefore, multiple approaches such as smoking cessation, counseling, and pharmaceutical therapies, targeting inflammation and oxidative stress are recommended for COPD treatment.
    AJP Lung Cellular and Molecular Physiology 05/2014; 307(3). DOI:10.1152/ajplung.00330.2013 · 4.04 Impact Factor